OptiAge

Aim: To examine the effect of low dose B vitamin supplementation (containing folic acid, B12, B6 and riboflavin in addition to vitamin D) for 2 years on bone health in TUDA participants.

Funders

Irish Department of Agriculture food and the Marine (DAFM)/DARD NI

Team

UU: Helene McNulty (PI), Mary Ward, Sean Strain

UCD: Lorraine Brennan, Michelle Clarke

Lay Summary

The OptiAge randomised controlled trial was conducted to examine the effect of low dose B vitamin supplementation (containing folic acid, B12, B6 and riboflavin in addition to vitamin D) for 2 years on bone health in approximately 200 TUDA participants.

Click here to view funding for each project